Nick Samra

Suggest Changes
Learn More
BACKGROUND Orally and intravenously administered proton pump inhibitors have been shown to reduce rebleeding rates, surgery and transfusion requirement. AIM To compare lansoprazole intravenous and(More)
  • 1